DE
dEsparbes Eric
Chief Financial Officer
OtherM
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by dEsparbes Eric, Chief Financial Officer. Officer active across 3 companies, notably PROGENITY, INC.. Aggregated, 14 filings have been published. History available since 15 August 2021. The latest transaction was disclosed on 15 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to dEsparbes Eric
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
27,830 shares@ US$0.6710.8% of flowCommon StockSEC:0000950170-24-098046:0
325,000 shares0Common StockSEC:0000950170-24-015862:0
40,022 shares@ US$3.1473.5% of flowCommon StockSEC:0000950170-23-043225:0
2,807 shares@ US$3.355.5% of flowCommon StockSEC:0000950170-23-022773:0
62,225 shares0Common StockSEC:0000899243-23-009032:0
269 shares@ US$3.460.6% of flowCommon StockSEC:0000899243-23-005465:0
95 sharesSeries X Preferred StockSEC:0000899243-23-000958:0
5,194 shares@ US$0.270.9% of flowCommon StockSEC:0000899243-22-036077:0
5,952 shares@ US$1.043.9% of flowCommon StockSEC:0000899243-22-028839:0
10,387 shares@ US$0.754.8% of flowCommon StockSEC:0000899243-22-018428:0
231,693 shares0Common StockSEC:0000899243-22-015063:0
4,919 shares@ US$1.9050.7% of flowCommon StockSEC:0000899243-22-006785:0
5,718 shares@ US$1.6649.3% of flowCommon StockSEC:0000899243-21-033252:0
115,734 sharesCommon StockSEC:0001179110-16-017813:0
About dEsparbes Eric
dEsparbes Eric is Chief Financial Officer. He has 14 filings in total, and in the sampled recent filings the activity runs from 2016-01-19 to 2024-08-16, with a dominant transaction nature tied to tax withholding. The largest individual amounts observed in that sample concern Biora Therapeutics, INC. and PROGENITY, INC.